Acceptance of adjuvant therapy and quality of life issues-Reference-Cited by-同舟云学术

Acceptance of adjuvant therapy and quality of life issues

Published:2005-12 Issue:6 Volume:14 Page:612-616
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Fallowfield Lesley

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference21 articles.

1. Determining the relationship between toxicity and quality of life in an ovarian cancer chemotherapy clinical trial;Butler;J Clin Oncol,2004

2. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30;Fromme;J Clin Oncol,2004

3. Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for ‘well-tolerated’ treatments?;Fellowes;Breast Cancer Res Treat,2001

4. Under-reporting of symptoms in patients with early breast cancer(EBC) who have received tamoxifen treatment for 2–3 years;Coombes;Proc Am Soc Clin Oncol,2003

5. He said/she said: how much common agreement is there on symptoms between common toxicity criteria and quality of life?;Savage;Proc Am Soc Clin Oncol,2002

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anxiety, depression, and quality of life in postoperative non-small cell lung cancer patients under the intervention of cognitive-behavioral stress management;Frontiers in Psychology;2023-05-31

2. The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis;PLOS ONE;2022-12-01

3. The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis;PLOS ONE;2021-02-05

4. Moving beyond the stage: how characteristics at diagnosis dictate treatment and treatment-related quality of life year losses for women with early stage invasive breast cancer;Expert Review of Pharmacoeconomics & Outcomes Research;2021-01-27

5. Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms – an update on the evidence;Climacteric;2020-10-06